These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36633541)

  • 1. In vitro and in vivo evaluation of DNase I in reinstating antibiotic efficacy against Klebsiella pneumoniae biofilms.
    Sharma A; Rishi P; Singh R
    Pathog Dis; 2023 Jan; 81():. PubMed ID: 36633541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of essential oil and ciprofloxacin to inhibit/eradicate biofilms in multidrug-resistant Klebsiella pneumoniae.
    Mohamed SH; Mohamed MSM; Khalil MS; Azmy M; Mabrouk MI
    J Appl Microbiol; 2018 Jul; 125(1):84-95. PubMed ID: 29517825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of different phases of biofilm of Klebsiella pneumoniae to three different antibiotics.
    Singla S; Harjai K; Chhibber S
    J Antibiot (Tokyo); 2013 Feb; 66(2):61-6. PubMed ID: 23168403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Resistance, Biofilm Formation, and Persistent Phenotype of
    Pham HN; Than TDN; Nguyen HA; Vu DH; Phung TH; Nguyen TK
    Microb Drug Resist; 2024 May; 30(5):203-209. PubMed ID: 38512170
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.
    Verma V; Harjai K; Chhibber S
    Biofouling; 2010 Aug; 26(6):729-37. PubMed ID: 20711894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
    J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model.
    Mataraci Kara E; Ozbek Celik B
    J Chemother; 2018 Apr; 30(2):82-88. PubMed ID: 29063819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa.
    Soares A; Alexandre K; Lamoureux F; Lemée L; Caron F; Pestel-Caron M; Etienne M
    J Antimicrob Chemother; 2019 Nov; 74(11):3252-3259. PubMed ID: 31424553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections.
    Shein AMS; Wannigama DL; Higgins PG; Hurst C; Abe S; Hongsing P; Chantaravisoot N; Saethang T; Luk-In S; Liao T; Nilgate S; Rirerm U; Kueakulpattana N; Laowansiri M; Srisakul S; Muhummudaree N; Techawiwattanaboon T; Gan L; Xu C; Kupwiwat R; Phattharapornjaroen P; Rojanathanes R; Leelahavanichkul A; Chatsuwan T
    Sci Rep; 2021 Nov; 11(1):21676. PubMed ID: 34737361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.
    Anderl JN; Franklin MJ; Stewart PS
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1818-24. PubMed ID: 10858336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.
    Verma V; Harjai K; Chhibber S
    J Antimicrob Chemother; 2009 Dec; 64(6):1212-8. PubMed ID: 19808232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Inhibitory Effects of Lactobacillus Supernatants and Their Metabolites on the Growth and Biofilm Formation of Klebsiella pneumoniae.
    Kheiri F; Kermanshahi RK; Feizabadi MM
    Infect Disord Drug Targets; 2020; 20(6):902-912. PubMed ID: 31903886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial and antibiofilm efficacy of Ag NPs, Ni NPs and Al
    Edhari BA; Mashreghi M; Makhdoumi A; Darroudi M
    J Trace Elem Med Biol; 2021 Dec; 68():126840. PubMed ID: 34425454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiofilm Activity of a Broad-Range Recombinant Endolysin LysECD7: In Vitro and In Vivo Study.
    Fursov MV; Abdrakhmanova RO; Antonova NP; Vasina DV; Kolchanova AD; Bashkina OA; Rubalsky OV; Samotrueva MA; Potapov VD; Makarov VV; Yudin SM; Gintsburg AL; Tkachuk AP; Gushchin VA; Rubalskii EO
    Viruses; 2020 May; 12(5):. PubMed ID: 32429199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
    Hostacká A; Ciznár I
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Klebsiella pneumoniae biofilm model mimicking in vivo system: altered morphological characteristics and antibiotic resistance.
    Singla S; Harjai K; Chhibber S
    J Antibiot (Tokyo); 2014 Apr; 67(4):305-9. PubMed ID: 24424347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
    She P; Liu Y; Xu L; Li Y; Li Z; Liu S; Hussain Z; Wu Y
    Front Cell Infect Microbiol; 2022; 12():858606. PubMed ID: 35372124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.